News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
273 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18005)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (331)
2 (134)
3 (3)
4 (4)
5 (239)
6 (297)
7 (254)
8 (229)
9 (142)
10 (7)
11 (9)
12 (228)
13 (282)
14 (268)
15 (254)
16 (160)
17 (2)
18 (5)
19 (218)
20 (259)
21 (132)
22 (18)
23 (29)
24 (4)
25 (14)
26 (221)
27 (273)
28 (265)
29 (229)
30 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Doctor Evidence CEO Awarded Two Honorary Fellowships
Robert Battista was recently selected for fellowship in the Royal College of Physicians of Edinburgh and the Royal Society for Public Health.
November 27, 2018
·
4 min read
Pharm Country
CRG Provides $65 Million Commitment, Positioning HNI Healthcare for Transformation
CRG today announced a $65 million commitment to HNI Healthcare (“HNI”), a technology-enabled physician practice management company focused on the delivery of full-service facility-based physician programs.
November 27, 2018
·
3 min read
Business
Daiichi Sankyo and Roche to Collaborate on New HER2 Low Companion Diagnostic Test
Daiichi Sankyo Company, Limited announced today that it has entered into an agreement with Roche to collaborate on the development of a new HER2 low companion diagnostic test.
November 27, 2018
·
5 min read
BioCapital
New HealthWell Foundation Fund Offers Financial Assistance to Patients Living with Congenital Sucrase-Isomaltase Deficiency (CSID)
Support Now Available to Assist with Copayments and Premiums
November 27, 2018
·
3 min read
FDA
United Orthopedic Corporation Announces FDA Clearance for Vitamin E Highly Cross-Linked Polyethylene Hip Liner
E-XPE™ Designed to Provide Wear Resistance with Reduced Risk of Oxidation is Now Available in Both Knee Inserts and Hip Liners
November 27, 2018
·
3 min read
Pharm Country
Eisai to Present New Research on HALAVEN® (eribulin mesylate) Injection at 41st Annual San Antonio Breast Cancer Symposium
Eisai announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (marketed as HALAVEN®) will be presented during the 41st San Antonio Breast Cancer Symposium (SABCS). The symposium will be held from December 4-8, 2018, in San Antonio, Texas.
November 27, 2018
·
8 min read
Business
Lilly to Announce 2019 Financial Guidance, Highlight Late-Stage Pipeline Opportunities and Discuss Commercial Performance at Upcoming Investment Community Meeting
Eli Lilly and Company today announced that it will host a meeting for the investment community on Wednesday, December 19, 2018, from 9:00 a.m. (EST) until approximately 12:00 p.m.
November 27, 2018
·
1 min read
Business
Zymeworks and BeiGene Announce License and Collaboration Agreement for Zymeworks’ HER2-Targeted Therapeutic Candidates, ZW25 and ZW49, in Asia-Pacific and Research and License Agreement for Zymeworks’ Azymetric™ and EFECT™ Platforms Globally
BeiGene acquires exclusive development and commercial rights to Zymeworks’ bispecific candidates, ZW25 and ZW49, in Asia (excluding Japan), Australia, and New Zealand. The companies will collaborate on joint global development for selected indications.
November 27, 2018
·
12 min read
Business
Dr. Mark C. Hutten Elected Vice President of the American College of Prosthodontists
Chicago-based dental specialist joins leadership of professional prosthodontic association
November 27, 2018
·
2 min read
Business
Hill-Rom Announces Executive Appointments Effective December 3, 2018.
Barbara Bodem to Succeed Steven J. Strobel as CFO
November 27, 2018
·
5 min read
Previous
27 of 28
Next